Concepedia

Mohsen Hemmati-Dinarvand

MH

7

Publications

157

Citations

7

H-Index

2017

Active since

Affiliations

Shiraz University of Medical Sciences(Current)

Tabriz University of Medical Sciences

Shahid Beheshti University of Medical Sciences

Hamedan University of Medical Sciences

Babol University of Medical Sciences

Mohsen Hemmati-Dinarvand is an author at Shiraz University of Medical Sciences specializing in medicine, tumor biology, and oxidative stress.

ORCID

Top concepts

Publications per year

2017–2024

7

Publications

7

Micheliolide Protects Against Doxorubicin-Induced Cardiotoxicity in Mice by Regulating PI3K/Akt/NF-kB Signaling Pathway

Ashkan Kalantary‐Charvadeh, Davoud Sanajou, Mohsen Hemmati-Dinarvand et al. · Cardiovascular Toxicology · 2019 · 46 citations

, , +9

Dysregulation of serum NADPH oxidase1 and ferritin levels provides insights into diagnosis of Parkinson's disease

Mohsen Hemmati-Dinarvand, Aliakbar Taheraghdam, Ali Mota et al. · Clinical Biochemistry · 2017 · 27 citations

, , +11

The Association between Serum Oxidative Stress Indexes and Pathogenesis of Parkinson's Disease in the Northwest of Iran

Haleh Barmaki, Ali Morovati, Zainab Eydivandi et al. · Iranian Journal of Public Health · 2021 · 21 citations · Full text

Correlation of PTEN signaling pathway and miRNA in breast cancer

Mahya Mohammadi, Ahmad Fazilat, Alireza Soleimani Mamalo et al. · Molecular Biology Reports · 2024 · 19 citations

, , +8

Nitazoxanide and Cancer Drug Resistance: Targeting Wnt/β-catenin Signaling Pathway

Mohsen Hemmati-Dinarvand, Hassan Ahmadvand, Atefeh Seghatoleslam · Archives of Medical Research · 2021 · 17 citations

, , +4

Rows per page

1–5 of 7